Generation and Characterization of a Unique Reagent that Recognizes a Panel of Recombinant Human Monoclonal Antibody Therapeutics in the Presence of Endogenous Human IgG
Domain Annotation: SCOP/SCOPe Classification SCOP-e Database Homepage
Domain Annotation: ECOD Classification ECOD Database Homepage
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
|---|---|---|---|---|---|---|---|---|
| A [auth X] | TraQ_transposon | e4k7pX1 | A: a/b three-layered sandwiches | X: immunoglobulin/albumin-binding domain-like | H: EGF-related | T: Complement control module/SCR domain | F: TraQ_transposon | ECOD (v294.1) |
| B [auth Y] | TraQ_transposon | e4k7pY1 | A: a/b three-layered sandwiches | X: immunoglobulin/albumin-binding domain-like | H: EGF-related | T: Complement control module/SCR domain | F: TraQ_transposon | ECOD (v294.1) |
| C [auth H] | TraQ_transposon | e4k7pH1 | A: a/b three-layered sandwiches | X: immunoglobulin/albumin-binding domain-like | H: EGF-related | T: Complement control module/SCR domain | F: TraQ_transposon | ECOD (v294.1) |
| D [auth L] | TraQ_transposon | e4k7pL1 | A: a/b three-layered sandwiches | X: immunoglobulin/albumin-binding domain-like | H: EGF-related | T: Complement control module/SCR domain | F: TraQ_transposon | ECOD (v294.1) |
Domain Annotation: CATH CATH Database Homepage
| Chain | Domain | Class | Architecture | Topology | Homology | Provenance Source (Version) |
|---|---|---|---|---|---|---|
| A [auth X] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| B [auth Y] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| C [auth H] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| D [auth L] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
IMGT Antibody Annotation IMGT Database Homepage
| Chain | Protein Name | Description | Organism Name | Gene Allele Name(s) | Domain Name(s) | Receptor Type | Receptor Description | Provenance Source |
|---|---|---|---|---|---|---|---|---|
| A [auth X] | RhumAb6 Fab | L-KAPPA | Homo sapiens (human) | IGKV1-12*01, IGKV1D-12*01, IGKV1-12*02, IGKV1D-12*02, IGKJ1*01, IGKC*01 | V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA | IG | FAB-GAMMA-1_KAPPA | IMGT (202612-0) |
| B [auth Y] | RhumAb6 Fab | VH-CH1 | Homo sapiens (human) | IGHV3-66*01, IGHV3-66*02, IGHV3-66*04, IGHV3-23*04, IGHJ4*01, IGHJ4*02, IGHJ4*03, IGHG1*01, IGHG1*02, IGHG1*04, IGHG1*05 | V-DOMAIN VH, C-DOMAIN CH1 | IG | FAB-GAMMA-1_KAPPA | IMGT (202612-0) |
| C [auth H] | 10C4 Fab, anti-IG Ab reagent | VH-CH1 | Chimeric (chimeric) | IGHV9-1*02, IGHJ1*01, IGHJ1*02, IGHG1*01, IGHG1*02, IGHG1*04, IGHG1*05 | V-DOMAIN VH, C-DOMAIN CH1 | IG | FAB-GAMMA-1_KAPPA | IMGT (202612-0) |
| D [auth L] | 10C4 Fab, anti-IG Ab reagent | L-KAPPA | Chimeric (chimeric) | IGKV12-44*01, IGKJ5*01, IGKC*01 | V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA | IG | FAB-GAMMA-1_KAPPA | IMGT (202612-0) |
SAbDab Antibody Annotation SAbDab Database Homepage
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|---|---|---|---|---|
| A [auth X] | Light Chain | IGKV1 | Kappa | - | SAbDab (2026-03-27) |
| B [auth Y] | Heavy Chain | IGHV3 | - | - | SAbDab (2026-03-27) |
| C [auth H] | Heavy Chain | IGHV9 | - | - | SAbDab (2026-03-27) |
| D [auth L] | Light Chain | IGKV12 | Kappa | - | SAbDab (2026-03-27) |
Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage
| Chain | Name | Target | Provenance Source |
|---|---|---|---|
| A [auth X] | Ocrelizumab | MS4A1/CD20 | Therapeutic SAbDab (2026-03-27) |
| B [auth Y] | Ocrelizumab | MS4A1/CD20 | Therapeutic SAbDab (2026-03-27) |
